ArticleHealth science reports2026
A Comparative Policy Review of Tuberculosis Infection Control Policies Across Six Countries: Insights on Screening, Prevention, and Treatment Strategies.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Tuberculosis (TB) infection remains one of the major global public health challenges, disproportionately affecting vulnerable and marginalized populations. This study aims to compare prevention, screening, and treatment policies for TB in selected countries to identify effective strategies and policy gaps that may inform national and international TB control programs. Methods: This comparative review analyzed the prevention, screening, and treatment policies of TB in Iran, the United States, Ireland, Japan, the United Kingdom, and Türkiye in 2023. Comprehensive searches were conducted in electronic databases (PubMed, Scopus, Web of Science, and Embase), as well as on the official websites of ministries of health and national TB programs in these countries. The inclusion criteria were the availability of policy documents addressing prevention, screening, and treatment, detailed information on implementation processes, and publication between 1993 and 2023. Data were extracted and synthesized based on the scope and structure of national TB strategies and alignment with WHO recommendations. Results: Findings indicated that the UK and the US have successfully implemented effective TB control policies through structured strategies, surveillance systems, and intersectoral coordination. Iran, Japan, and Türkiye achieved notable reductions in TB mortality by adopting similar evidence-based policies. Although Ireland demonstrated a decline in incidence, its treatment success rate remained comparatively low. Challenges identified across countries included Multi-Drug-Resistant Tuberculosis (MDR-TB), inequitable distribution of health services, limited financial and human resources, structural deficiencies in health systems, inadequate coordination of care, social stigma, and barriers related to migrant populations, which have collectively hindered TB control, especially in treatment. Conclusion: Effective TB control requires strengthening health system capacity, implementing integrated and active prevention programs, expanding screening among high-risk and migrant populations, improving surveillance systems, and preventing drug-resistant TB. Adequate financial investment, trained human resources, and coordinated policy implementation remain essential for sustainable TB control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.